Institutional investors purchased a net $826.5 thousand shares of VSTM during the quarter ended June 2015. This may signal that the smart money is gaining interest in this company as the 57.12% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
AXA INVESTMENT MANAGERS (PARIS) ... Bought 168.9 Thousand shares of Verastem Inc